Form 4: Roivant Sciences Director Keith Manchester Reports Changes in Beneficial Ownership

Keith Manchester, a director of Roivant Sciences, reported changes in his beneficial ownership of common shares due to an in-kind distribution and vesting of restricted stock units.

Summary

• On March 7, 2024, Keith Manchester, a director of Roivant Sciences Ltd., filed a Form 4 with the SEC reporting changes in his beneficial ownership of the company's common shares.
• The changes are due to an in-kind distribution from QVT Roiv Hldgs Onshore Ltd., QVT P&E Roiv Hldgs Ltd., QVT Deferred Compensation Holdings Ltd, and QVT Financial Investment Cayman Ltd., for no consideration.
• Manchester also received shares as part of this distribution and from restricted stock units (RSUs) that vested on September 15, 2023.
• Additionally, he holds RSUs scheduled to vest on September 12, 2024, subject to continuous service.
• Manchester disclaims beneficial ownership of shares held by the QVT Entities, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the transactions described do not inherently indicate positive or negative sentiment.

Positives

• The vesting of RSUs indicates continued alignment of the director's interests with the company's performance.

Future Outlook

The reporting person holds RSUs that are scheduled to vest in the future, contingent on continued service.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the ownership stake of a company director.

Key Dates